DNMT1 expression was associated with age of the patients, menopause status, and tumor localization, while DNMT3a expression was associated with histological types and serum CA125 levels and DNMT3b expression was associated with lymph node metastasis. This evidence concerns the gene DNMT3B and metastatic malignant neoplasm in the lymph nodes.